ADIPOQ and cardiovascular disorder: Therefore, since the clinical significance of adiponectin as a biomarker in cardiovascular diseases remains controversial, the implications of decreased levels of adiponectin associated with Gnetin-C intake, as we observed in the present study, are currently unknown.